ARCHIVES

The NLST at a Glance

This article is from The Cancer Letter archive.

Vol. 39 No. 31 | August 2, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

July 28, 2000

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992

In Brief: NIH Appeals Board Restores Nassau CCOP Funding, PI Says It Is Now Meeting Patient Accrual Goal

February 22, 1985